New IDF guidelines raise importance of post-meal glucose control

Diabetes :: New IDF guidelines raise importance of post-meal glucose control

The International Diabetes Federation (IDF) has published new guidelines on the contribution and impact of post-meal glucose in diabetes disease management at the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD) on September_19, 2007. The IDF recognises the growing evidence that post-meal glucose is a key contributor to overall glycaemic control – particularly with respect to HbA1C levels, and that reducing post-meal glucose has a significant impact on the risk of developing diabetic complications.

The new guidelines include a specific reference to acarbose (Glucobay®*) as a pharmacological agent with a substantial body of evidence proving that it lowers post-meal glucose and thereby effectively reduces the risks associated with high post-meal glucose levels.

Acarbose lowers post-meal blood glucose and HbA1C in an effective and well tolerated manner, and reduces the risk of cardiovascular complications in patients with type 2 diabetes.1 The benefits of acarbose are evident in individuals at a high risk of developing diabetes (pre-diabetes), in whom it reduces risks of diabetes and serious cardiovascular events.2, 3

Professor Pierre Lefèbvre, immediate past president of the IDF, highlighted that interest in post-meal glucose started 30 years ago with Bayer’s discovery that acarbose lowers post-meal hyperglycaemia. Acarbose is one of a number of pharmacological agents recommended in the guidelines to lower post-meal glucose.

The recommendation for acarbose is supported by the results of the Study to Prevent Non-Insulin Dependent Diabetes Mellitus (STOP-NIDDM) and the Metaanalysis of Risk Improvement under Acarbose (MeRIA).2-5

Professor Antonio Ceriello, chair of the Guideline Development Steering Committee, presented the key recommendations from the guidelines:

Post-meal hyperglycaemia is harmful and should be addressed.
Treatment strategies to lower post-meal plasma glucose in people with post-meal hyperglycaemia should be implemented.
Two-hour post-meal plasma glucose should not exceed 7.8 mmol/l (140 mg/dl) as long as hypoglycaemia is avoided.
A variety of both non-pharmacologic and pharmacologic therapies should be considered to target post-meal plasma glucose.

The diabetic population is increasing by 7 million each year, with almost 4 million deaths, the majority of which arise from macrovascular complications. There is a real need to raise awareness and to integrate the recommendations of the IDF into clinical practice. The steering committee acknowledged the challenges of measuring post-meal glucose in the clinic, but recommended innovative approaches such as the use of risk prediction tools to identify high-risk individuals.

* in some countries: Glucor®, Prandase®, Precose®

References
1. Van de Laar F, et al. Diabetes Care 2005;28:154–75.
2. Chiasson JL, et al. Lancet 2002;359:2072–7.
3. Chiasson JL, et al. JAMA 2003;290:486–94.
4. Hanefeld M, et al. Stroke 2004;35:1073–78.
5. Hanefeld M, et al. Eur Heart J 2004;25:10–16.




(Diabetes :: New IDF guidelines raise importance of post-meal glucose control published at SpiritIndia on Sunday, October 7, 2007)

Diabetes

Search more information on Diabetes, Diabetes books

Recently posted related articles on Diabetes :

1. Diabetes :: 63 percent of diabetics risk serious foot problems by wearing the wrong-sized shoes
2. Diabetes :: India to launch special programme to control diabetes
3. Diabetes :: Stanford researchers shed light on gestational diabetes
4. Diabetes :: The new source of islet cells
5. Diabetes :: European Medicine Agency confirms positive Avandia benefit risk assessment
6. Pancreatitis :: Diabetes drug Byetta, exenatide may cause acute pancreatitis
7. Diabetes :: PGC-1-alpha helps skeletal muscle and pancreatic islets communicate
8. Blood Pressure :: Women with high or increasing blood pressure are up to three times more likely to develop diabetes
9. Diabetes :: New IDF guidelines raise importance of post-meal glucose control
10. Diabetes :: Solving a critical part of the insulin puzzle

Most related articles:

- Diabetes :: New IDF guidelines raise importance of post-meal glucose control
- Diabetes :: Value of glucose monitoring for non-insulin diabetes patients ? - 9.9
- Diabetes :: Healthy Diabetic Diet for Diabetics - 9.3
- Diabetes :: Type 2 diabetics should avoid Caffeine to control Blood Sugar - 8.9
- Diabetes :: Inhaled insulin benefits type 2 diabetics - 8.7
- Pregnancy :: Pregnant women most at risk of diabetes can be identified by a simple blood test - 8.6
- Diabetes :: Penn researchers find potential new target for Type 2 diabetes - 8.5
- GI Diet :: Glycaemic index or GI - 8.2
- Diabetes :: New storage instructions approved for Byetta - 8.2
- Diabetes :: Exercise pivotal in preventing and fighting type II diabetes - 7.7

Diabetes - recent related articles/news stories:

- Gene Deaf1 may play a role in type 1 diabetes
- Pancreatic cancer risk reduced by diabetes drug metformin
- Low birth weight linked to diabetes gene CDKAL1
- Treating obesity with brown fat in the body
- Antipsychotics raise blood sugar in older diabetes patients

»»   Medicare :: Medicare expects to recover $4 billion from Part D plans following 2006 plan reconciliation
««   AHF's Innovative - Stay Negative - HIV Prevention Campaign

Home | Cancer | Therapies | Diet | Herbs | Heart | Skin | Cosmetic Surgery | Arthritis | Allergies | Eyes | GIT | Glossary | List

AYUSH = Ayurveda - Yoga - Unani - Siddha - Homeopathy -- Health articles

The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Spirit India comply with the HONcode principles for trustworthy health information.
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com